Short answer: yes. The patent landscape for biosynthesis of human milk oligosaccharides (HMOs) includes several overlapping families, driven largely by two broad routes (enzymatic synthesis and microbial production) and by claims around specific HMOs (e.g., 2’-FL, LNnT/LNT, and various sialylated HMOs). Because the field has matured over the past decade, many early families have matured, expired or entered new divisions, and new entrants continue to file around the same target HMOs, leading to overlapping claims across jurisdictions.
What tends to overlap and how to think about it
- Production route overlap:
- Enzymatic synthesis patents claim sequences of glycosyltransferase steps and enzyme cocktails to assemble HMOs from simpler sugars (often lactose derivatives).
- Microbial biosynthesis patents claim engineered hosts (bacteria or yeast) and pathway designs to produce HMOs directly in fermentation. These two tracks frequently converge on the same HMOs (e.g., 2’-FL) but through different mechanisms, creating potential cross-coverage in terms of the same product.
- Target HMOs and host overlap:
- For widely marketed HMOs like 2’-FL and LNnT (and their combination products), you’ll commonly see multiple families each claiming a version of the same end product, sometimes with different hosts, enzyme sets, or process steps.
- Sialylated HMOs (e.g., 3’-SL, 6’-SL) also show multiple families, sometimes focusing on different hosts or biosynthetic routes.
- Jurisdictional breadth:
- Overlaps are common across major markets (US, Europe, China/Korea/Japan). A patent family might be active in one market and not in another, but related families from the same applicant or licensees often appear in multiple jurisdictions.
- downstream processing and process claims:
- In addition to core biosynthetic claims, many families cover purification/downstream steps, formulation, and product purity specs. This can add to overlap when a single HMO product is claimed with a broad downstream process.
How to perform a practical landscape check (starter plan)
- Define scope: pick the HMOs you care about (e.g., 2’-FL, LNnT, LNT, 3’-SL, 6’-SL) and decide whether you want to cover only biosynthesis or also downstream processing and composition claims.
- Databases to search:
- Google Patents, Espacenet (European patent database), and Lens.org for a broad sweep.
- Consider country-specific patent offices (USPTO, EPO, CNIPA, JPO, KIPO) for status and enforcement details.
- Key search terms to run:
- “human milk oligosaccharide biosynthesis”
- “2’-fucosyllactose production”
- “LNnT production” or “lacto-N-neotetraose production”
- “lacto-N-tetraose biosynthesis”
- “sialylated HMO production” (3’-SL, 6’-SL)
- “engineered microorganism” and terms like “Escherichia coli,” “Saccharomyces cerevisiae,” or “yeast” in combination with the above HMOs
- “glycosyltransferase,” “fucosyltransferase,” “sialyltransferase” in combination with HMOs
- Cluster and map results:
- Group patents into families by priority date, assignee, and core claim (e.g., enzymatic route to 2’-FL, microbial host production of LNnT, purification of HMOs, etc.).
- Note overlap by identifying families that claim the same HMO produced by overlapping routes (same product, different hosts or methods).
- Mark status (pending, granted, expired, maintenance fees paid) and jurisdictions.
- Pay attention to:
- Family breadth (claims that cover “a method to produce X in a host” vs. “X produced in a host Y”) and claim language that could capture multiple HMOs.
- Cross-licensing activity or license-forward statements in the patent text.
- Continuations/divisions that may extend coverage or capture new host systems.
What I can offer next
- If you share specifics (which HMOs you care about, target jurisdiction(s), whether you need freedom-to-operate for a product vs. a research program), I can assemble a focused starter landscape:
- a categorized list of patent families and key assignees
- a quick overlap matrix showing where claims potentially intersect
- status notes (granted/pending/expired) and typical claim scope
- I can also provide a search plan you or your patent team can execute in a stepwise fashion, plus tips on how to interpret claim language that often determines overlap (e.g., broad host claims vs. specific enzymes, product-by-process claims, and “wherein” language that broadens coverage).
Important caveats
- The patent landscape is dynamic: new families appear, statuses change (grants, reexaminations, oppositions), and expirations alter FTO considerations. A current, jurisdiction-specific landscape is best done with up-to-date database searches and, if needed, a patent attorney or a professional search firm.
- I can’t replace a formal FTO opinion, but I can help you get a coherent, up-to-date lay of the land and prepare the input you’d need for a formal analysis.
If you want, tell me:
- Which HMOs are of primary interest (e.g., 2’-FL, LNnT, LNT, 3’-SL, 6’-SL)
- Target markets/jurisdictions
- Whether you’re evaluating for a product (end-use ingredient) or a research project
I’ll tailor a concise starter landscape and a concrete search plan.